4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001673232-25-000013
PRESIDENT AND COO sold 22,500 shares at $473.66 ($10,657,280)
- PRESIDENT AND COO acquired 22,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
BENKOWITZ MICHAEL · PRESIDENT AND COO
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-11-24 | Exercise or conversion : show line 1 in the form 10b5-1 | +2,625 | $117.76 | $309,120 | 2,625 | I |
| 2025-11-24 | Sale : show line 2 in the form 10b5-1 | −2,625 | $473.66 | $1,243,349 | 0 | I |
| 2025-11-24 | Exercise or conversion : show line 3 in the form 10b5-1 | +12,000 | $135.42 | $1,625,040 | 12,000 | I |
| 2025-11-24 | Sale : show line 4 in the form 10b5-1 | −12,000 | $473.66 | $5,683,883 | 0 | I |
| 2025-11-24 | Exercise or conversion : show line 5 in the form 10b5-1 | +7,875 | $146.03 | $1,149,986 | 7,875 | I |
| 2025-11-24 | Sale : show line 6 in the form 10b5-1 | −7,875 | $473.66 | $3,730,048 | 0 | I |
| Open-market sales · 22,500 sh · avg $473.66 · $10,657,280 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2025-11-24 | Exercise or conversion : show line 7 in the form 10b5-1 Stock Option | −12,000 | $135.42 | 2027-03-15 | 12,000 | 0 | I |
| 2025-11-24 | Exercise or conversion : show line 8 in the form 10b5-1 Stock Options | −2,625 | $117.76 | 2027-03-15 | 2,625 | 184,875 | I |
| 2025-11-24 | Exercise or conversion : show line 9 in the form 10b5-1 Stock Options | −7,875 | $146.03 | 2027-03-15 | 7,875 | 29,815 | I |
Loading xslF345X05/primarydocument.xml…